Agents that increase cellular cyclic AMP or calcium stimulate prolactin release from the 235-1 pituitary cell line.
The 235-1 pituitary tumor clone was utilized to study prolactin secretion after perturbing cyclic AMP and calcium metabolism. Cellular cyclic AMP levels were elevated after treatment with PGE1, cholera toxin, forskolin, isobutylmethylxanthine as well as dibutryl cyclic AMP; these cyclic AMP responses were associated with increased prolactin release. Ionophore A23187 and maitotoxin, which enhance calcium uptake into cells, also amplified prolactin secretion. In contrast, the calmodulin antagonists penfluridol and W7 reduced basal prolactin release. These data support the hypothesis that cyclic AMP, calcium and calmodulin can participate in prolactin release from 235-1 cells.
Schettini
G
G
Rogol
A D
AD
MacLeod
R M
RM
Yasumoto
T
T
Cronin
M J
MJ
D000818:Animals; D002118:Calcium / Q000502:physiology*; D002147:Calmodulin / Q000502:physiology*; D002999:Clone Cells; D000242:Cyclic AMP / Q000502:physiology*; D007473:Ion Channels / Q000502:physiology; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D010911:Pituitary Neoplasms; D011388:Prolactin / Q000378:metabolism*; D051381:Rats
D002147:Calmodulin; D007473:Ion Channels; D011388:Prolactin; D000242:Cyclic AMP; D002118:Calcium